Fuller & Thaler Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-458,144
| Closed | -$75.7M | – | 562 |
|
|
2021
Q2 | $75.7M | Buy |
458,144
+7,548
| +2% | +$1.25M | 0.49% | 68 |
|
|
2021
Q1 | $69.1M | Buy |
450,596
+568
| +0.1% | +$87.1K | 0.49% | 68 |
|
|
2020
Q4 | $56.5M | Sell |
450,028
-1,587
| -0.4% | -$199K | 0.52% | 67 |
|
|
2020
Q3 | $45.8M | Buy |
451,615
+1,815
| +0.4% | +$184K | 0.58% | 63 |
|
|
2020
Q2 | $43.8M | Buy |
449,800
+242,348
| +117% | +$23.6M | 0.57% | 65 |
|
|
2020
Q1 | $17.2M | Buy |
207,452
+155,344
| +298% | +$12.9M | 0.29% | 106 |
|
|
2019
Q4 | $5.79M | Buy |
52,108
+21,579
| +71% | +$2.4M | 0.06% | 208 |
|
|
2019
Q3 | $3.03M | Buy |
30,529
+46
| +0.2% | +$4.56K | 0.04% | 248 |
|
|
2019
Q2 | $3.02M | Buy |
30,483
+46
| +0.2% | +$4.56K | 0.04% | 241 |
|
|
2019
Q1 | $3.36M | Buy |
30,437
+1,022
| +3% | +$113K | 0.04% | 222 |
|
|
2018
Q4 | $2.71M | Sell |
29,415
-31,025
| -51% | -$2.85M | 0.04% | 242 |
|
|
2018
Q3 | $6.66M | Sell |
60,440
-67,860
| -53% | -$7.48M | 0.07% | 189 |
|
|
2018
Q2 | $12M | Buy |
128,300
+5,000
| +4% | +$467K | 0.13% | 135 |
|
|
2018
Q1 | $10.2M | Buy |
123,300
+8,300
| +7% | +$689K | 0.12% | 135 |
|
|
2017
Q4 | $10.5M | Buy |
115,000
+61,700
| +116% | +$5.62M | 0.13% | 120 |
|
|
2017
Q3 | $4.06M | Buy |
53,300
+32,200
| +153% | +$2.45M | 0.05% | 188 |
|
|
2017
Q2 | $1.58M | Buy |
21,100
+11,300
| +115% | +$848K | 0.02% | 247 |
|
|
2017
Q1 | $639K | Buy |
9,800
+2,100
| +27% | +$137K | 0.01% | 295 |
|
|
2016
Q4 | $424K | Buy |
7,700
+5,500
| +250% | +$303K | 0.01% | 310 |
|
|
2016
Q3 | $124K | Buy |
+2,200
| New | +$124K | ﹤0.01% | 424 |
|